News|Articles|September 14, 2026

Chirality Under the Microscope: What SFC Reveals About a Cancer-Fighting Ruthenium Complex

Daniel W. Armstrong explains how SFC confirmed mirror-image ruthenium photosensitiz-ers perform identically against melanoma cells.

Chiral metal complexes are getting a fresh look as potential drugs, but unlike organic drug candidates, their "handedness," or chirality, rarely gets the same rigorous scrutiny before researchers draw conclusions about how well they work.

Related to this article

Basel, Switzerland. Old town with red stone Munster cathedral on the Rhine river. © SCStock - stock.adobe.com
SFC Europe 2026 brings global experts to Basel for courses, scientific talks, workshops, and insights into greener separation technologies.